The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research.

By M. Bennett, Blair H. Smith, N. Torrance, Jean Potter. Journal of Pain, 2005

672 citations recorded by the source corpus.

Subfields: Neurology, Pharmacology, Physiology

View Paper: https://www.semanticscholar.org/paper/98de96dd89b9b1016d2d931b43c74e479aee5b59

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Blair H. Smith
2. N. Torrance

In Pharmacology

1. Blair H. Smith
2. D. Turk
3. N. Torrance
4. Henrik Kehlet
5. F. Perkins

In Physiology

1. Blair H. Smith
2. N. Torrance
3. Henrik Kehlet
4. F. Perkins

Citations in the corpus

• Development and initial validation of an expanded and revised version of the Short‐form McGill Pain Questionnaire (SF‐MPQ‐2) (2009, background): “Although our distinction between neuropathic and non-neuropathic pain was based on current diagnostic approaches [44], its validity is further mitigated by the heterogeneity of neuropathic pain and its underlying mechanisms and the existence of chronic pain conditions— for example, low back pain—tha”
• Neuropathic pain in the general population: A systematic review of epidemiological studies (2014, methodology): “22 NeuP, neuropathic pain; DN4, Douleur Neuropathique en 4 questions; N/A, not applicable, CI, confidence interval; PHN, postherpetic neuralgia; HZ, herpes zoster; HZV, Herpes Zoster Virus; PDPN, painful diabetic peripheral neuropathy; TN, trigeminal neuralgia; GN, glossopharyngeal neuralgia; ICPC, ”